Greiner Bio-One to Introduce Innovative Lab Products at Analytica
|
By LabMedica International staff writers Posted on 15 Apr 2014 |
|
Image: New ThinCert cell culture inserts coated with collagen type I (Photo courtesy of Greiner Bio-One).
Image: New Cryo.s biobank tubes for high-throughput sample storage in automated storage systems (Photo courtesy of Greiner Bio-One).
Image: CELLview slide with a removable housing that divides the slide into ten round compartments (Photo courtesy of Greiner Bio-One).
A company that counts among its customers the world’s largest labs, biotech, and pharmaceutical companies will introduce six new products at the analytica trade fair, in May 2014.
Greiner Bio-One (Frickenhausen, Germany) will showcase six innovative new products at analytica 2014, which will be held from May 10–13, in Munich (Germany). The Austro-German company, a technology partner for the diagnostic and pharmaceutical industries, is demonstrating its commitment to research and development.
With the new Cryo.s biobank tubes, Greiner Bio-One, which has been developing products for cryogenic storage for 30 years, is expanding its product portfolio to include a solution for high-throughput sample storage in automated storage systems. A new box in the standard 133 mm square format for the existing 1 mL, 2 mL and 4 mL Cryo.s freezing vials is also being unveiled at analytica, offering space for 81 Cryo.s vials. Openings on the bottom of the box enable a scanner to read the datamatrix codes without having to remove the vials.
Two innovations for the microscopy sector will be exhibited by Greiner Bio-One. One of them is the 384 well Screenstar microplates that can be used for high-throughput and high-content screening and high-resolution microscopy. The other solution for microscopy is a development from the Cellview product family––the Cellview slide. This is equipped with a removable housing that divides the slide into ten round compartments. To start with, ten independent cell cultures can be carried out for processing in a single operation after removing the housing.
In the field of cell cultivation, Greiner Bio-One is introducing the new ThinCert cell culture inserts coated with collagen type I at Analytica 2014. The additional coating with native collagen type I accelerates growth and differentiation processes several times over.
To simplify users' liquid handling, Greiner Bio-One has developed new colored inserts for Sapphire pipette tip boxes. The customized coloring is designed to help users identify more quickly which size of pipette tips is held by a particular box holds.
"Research and development are extremely important to us as a development-driven medium-sized enterprise," said Heinz Schmid, managing director of Greiner Bio-One GmbH. "As the leading trade fair for laboratory technology, analysis and biotechnology, analytica is a key platform for us to present our new products to customers and other interested parties."
Related Links:
Greiner Bio-One
Analytica
Greiner Bio-One (Frickenhausen, Germany) will showcase six innovative new products at analytica 2014, which will be held from May 10–13, in Munich (Germany). The Austro-German company, a technology partner for the diagnostic and pharmaceutical industries, is demonstrating its commitment to research and development.
With the new Cryo.s biobank tubes, Greiner Bio-One, which has been developing products for cryogenic storage for 30 years, is expanding its product portfolio to include a solution for high-throughput sample storage in automated storage systems. A new box in the standard 133 mm square format for the existing 1 mL, 2 mL and 4 mL Cryo.s freezing vials is also being unveiled at analytica, offering space for 81 Cryo.s vials. Openings on the bottom of the box enable a scanner to read the datamatrix codes without having to remove the vials.
Two innovations for the microscopy sector will be exhibited by Greiner Bio-One. One of them is the 384 well Screenstar microplates that can be used for high-throughput and high-content screening and high-resolution microscopy. The other solution for microscopy is a development from the Cellview product family––the Cellview slide. This is equipped with a removable housing that divides the slide into ten round compartments. To start with, ten independent cell cultures can be carried out for processing in a single operation after removing the housing.
In the field of cell cultivation, Greiner Bio-One is introducing the new ThinCert cell culture inserts coated with collagen type I at Analytica 2014. The additional coating with native collagen type I accelerates growth and differentiation processes several times over.
To simplify users' liquid handling, Greiner Bio-One has developed new colored inserts for Sapphire pipette tip boxes. The customized coloring is designed to help users identify more quickly which size of pipette tips is held by a particular box holds.
"Research and development are extremely important to us as a development-driven medium-sized enterprise," said Heinz Schmid, managing director of Greiner Bio-One GmbH. "As the leading trade fair for laboratory technology, analysis and biotechnology, analytica is a key platform for us to present our new products to customers and other interested parties."
Related Links:
Greiner Bio-One
Analytica
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Homocysteine Quality Control
Liquichek Homocysteine Control
Automatic CLIA Analyzer
Shine i9000
Latest Technology News
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
- Aptamer Biosensor Technology to Transform Virus Detection
- AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
- Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
- Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Industry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more